ArticlePLoS neglected tropical diseases2025
Socioeconomic and ecological drivers of snakebite incidence in Mexico: A spatial analysis of risk factors.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Strengthening public health programmes and the antivenom ecosystem: strategic policy priorities to combat envenomation by animal bites and stings in Latin America and the Caribbean.Journal of global health · 2026Article
- Persistent spatial hotspots and socioeconomic inequalities of snakebite envenoming in Peru: A nationwide spatiotemporal analysis, 2010-2025.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundSnakebite envenoming constitutes a significant public health challenge in tropical and subtropical regions, with Mexico reporting substantial incidence rates in the Americas. While previous investigations have documented the socioeconomic burden of snakebites, particularly in economically marginalized regions, a comprehensive understanding of the relative contributions of biological and socioeconomic determinants to spatial heterogeneity in snakebite incidence remains poorly understood. This study aimed to identify and quantify the main determinants of snakebite spatial heterogeneity across Mexico while accounting for potential reporting biases in surveillance data. METHODS/PRINCIPAL
findingsWe implemented a rigorous Bayesian analytical framework utilizing a conditional autoregressive zero-inflated Poisson model to examine snakebite incidence across 2,463 Mexican municipalities. Our methodological approach integrated three critical components: environmental suitability indices for venomous snake species derived from refined species distribution models, socioeconomic vulnerability metrics, and healthcare accessibility parameters. Social lag index (β = 0.308, 95% CI: 0.106-0.522), road network density (β = 0.376, 95% CI: 0.215-0.539), and environmental suitability for Bothrops asper (β = 0.268, 95% CI: 0.047-0.504) emerged as the primary factors explaining spatial variation in snakebite incidence. Healthcare facility distribution (β = 0.225, 95% CI: 0.126-0.326) was identified as a significant source of reporting bias. After controlling for this bias, our model revealed substantially different spatial pattern of risk, with elevated predicted incidence in urban centers and specific coastal regions not previously identified as high-risk areas.
conclusionsOur findings demonstrate that snakebite risk in Mexico is driven by a complex interaction between social vulnerability, infrastructure development, and the distribution of key venomous snake species. The identification of systematic reporting biases offers critical insights for optimizing surveillance protocols and implementing targeted interventions in high-risk municipalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.